Editorial Staff

  • Executive Editor/VP-Special Projects:
    Jeff Hall
  • Senior Editor
    Brian McCurdy
  • Circulation and Subscriptions
    Bonnie Shannon
  • Art Director:
    Alana Balboni
  • Editorial Correspondence

  • Jeff Hall, Executive Editor/VP-Special Projects, Podiatry Today
  • HMP Communications, 83 General Warren Blvd
    Suite 100, Malvern PA 19355
  • Telephone: (800) 237-7285, ext. 214
    Fax: (610) 560-0501
  • Email: jhall@hmpcommunications.com
  • January 2003 | Volume 16 - Issue 1
    Clinical Editor: Lawrence Karlock, DPM
    6,413 reads | 0 comments | 01/03/03
    As Aristidis Veves, MD and Thanh Dinh, DPM, point out, it is well-known that the chronic diabetic foot ulcer is stuck in the inflammation phase of the wound healing cycle. Research studies have shown that non-healing wounds may have specific biochemical imbalances, notes Liza Ovington, PhD. In particular, non-healing wounds have been shown to have excessively high levels of proteolytic enzymes such as matrix metalloproteases (MMPs). While these enzymes are necessary in various aspects of the healing process, such as cellular migration, debridement and phagocytosis, Dr. Ovington notes that hi ... continue reading
    By Lowell Scott Weil Jr., DPM
    50,557 reads | 0 comments | 01/03/03
    While the great majority of hallux valgus deformities can be accommodated with a wide toe-box shoe, secondary deformities, such as painful hammer digit syndrome and metatarsalgia, coupled with patient demands, often drive the need for operative intervention. In addition, some individuals are averse to wearing any type of special shoes and wish to have the deformity corrected rather than accommodated. When an operation is indicated in your opinion and in concert with the patient’s wishes, the goals for the ideal hallux valgus operation are as follows: • joint congruity with full, pain-fre ... continue reading